Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

Heap GA, So K, Weedon M, Edney N, Bewshea C, Singh A, Annese V, Beckly J, Buurman D, Chaudhary R, Cole AT, Cooper SC, Creed T, Cummings F, de Boer NK, D'Inca R, D'Souza R, Daneshmend TK, Delaney M, Dhar A, Direkze N, Dunckley P, Gaya DR, Gearry R, Gore S, Halfvarson J, Hart A, Hawkey CJ, Hoentjen F, Iqbal T, Irving P, Lal S, Lawrance I, Lees CW, Lockett M, Mann S, Mansfield J, Mowat C, Mulgrew CJ, Muller F, Murray C, Oram R, Orchard T, Parkes M, Phillips R, Pollok R, Radford-Smith G, Sebastian S, Sen S, Shirazi T, Silverberg M, Solomon L, Sturniolo GC, Thomas M, Tremelling M, Tsianos EV, Watts D, Weaver S, Weersma RK, Wesley E, Holden A, Ahmad T.

J Crohns Colitis. 2016 Feb;10(2):149-58. doi: 10.1093/ecco-jcc/jjv219. Epub 2015 Nov 29. Erratum in: J Crohns Colitis. 2017 Dec 4;11(12):1509.

PMID:
26619893
2.

HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.

Heap GA, Weedon MN, Bewshea CM, Singh A, Chen M, Satchwell JB, Vivian JP, So K, Dubois PC, Andrews JM, Annese V, Bampton P, Barnardo M, Bell S, Cole A, Connor SJ, Creed T, Cummings FR, D'Amato M, Daneshmend TK, Fedorak RN, Florin TH, Gaya DR, Greig E, Halfvarson J, Hart A, Irving PM, Jones G, Karban A, Lawrance IC, Lee JC, Lees C, Lev-Tzion R, Lindsay JO, Mansfield J, Mawdsley J, Mazhar Z, Parkes M, Parnell K, Orchard TR, Radford-Smith G, Russell RK, Reffitt D, Satsangi J, Silverberg MS, Sturniolo GC, Tremelling M, Tsianos EV, van Heel DA, Walsh A, Watermeyer G, Weersma RK, Zeissig S, Rossjohn J, Holden AL; International Serious Adverse Events Consortium; IBD Pharmacogenetics Study Group, Ahmad T.

Nat Genet. 2014 Oct;46(10):1131-4. doi: 10.1038/ng.3093. Epub 2014 Sep 14.

3.

A possible secondary case of pneumococcal meningitis.

Razzaq N, Riordan T, McNinch AW, Daneshmend TK.

J Infect. 1998 Nov;37(3):290-1.

PMID:
9892535
4.
5.

Filgrastim for mesalazine-associated neutropenia.

Wyatt S, Joyner MV, Daneshmend TK.

Lancet. 1993 Jun 5;341(8858):1476. No abstract available.

PMID:
8099166
6.

Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial.

Hawthorne AB, Daneshmend TK, Hawkey CJ, Belluzzi A, Everitt SJ, Holmes GK, Malkinson C, Shaheen MZ, Willars JE.

Gut. 1992 Jul;33(7):922-8.

7.

Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial.

Daneshmend TK, Hawkey CJ, Langman MJ, Logan RF, Long RG, Walt RP.

BMJ. 1992 Jan 18;304(6820):143-7.

8.

Separation of the impairment of haemostasis by aspirin from mucosal injury in the human stomach.

Hawkey CJ, Hawthorne AB, Hudson N, Cole AT, Mahida YR, Daneshmend TK.

Clin Sci (Lond). 1991 Oct;81(4):565-73.

PMID:
1657506
9.

A comparison of roxatidine and ranitidine for the acute treatment of duodenal ulcer.

Walt RP, Logan RF, Hawkey CJ, Daneshmend TK, Long RG, Cooper BT, Langman MJ, Collins M, Street R.

Aliment Pharmacol Ther. 1991 Jun;5(3):301-7.

PMID:
1679668
10.

Mesalazine-associated thrombocytopenia.

Daneshmend TK.

Lancet. 1991 May 25;337(8752):1297-8. No abstract available.

PMID:
1674100
11.
12.

Effect of smoking on prostaglandin, thromboxane and leukotriene synthesis by human gastric mucosa.

Hudson N, Daneshmend TK, Hurst S, Bhaskar NK, Brown NS, Hawkey CJ.

Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:777-9. No abstract available.

PMID:
1847575
13.

Diseases and drugs but not food decrease ketoconazole 'bioavailability'.

Daneshmend TK.

Br J Clin Pharmacol. 1990 Jun;29(6):783-4. No abstract available.

14.

Abolition by omeprazole of aspirin induced gastric mucosal injury in man.

Daneshmend TK, Stein AG, Bhaskar NK, Hawkey CJ.

Gut. 1990 May;31(5):514-7.

15.

Effect of reactive pharmacy intervention on quality of hospital prescribing.

Hawkey CJ, Hodgson S, Norman A, Daneshmend TK, Garner ST.

BMJ. 1990 Apr 14;300(6730):986-90.

16.

Effect of ranitidine and indomethacin on nocturnal gastric acidity in normal subjects.

Walt RP, Daneshmend TK, Prichard P, Langman MJ.

Aliment Pharmacol Ther. 1990 Apr;4(2):171-6.

PMID:
2104083
17.

Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine.

Kitchingman GK, Prichard PJ, Daneshmend TK, Walt RP, Hawkey CJ.

Br J Clin Pharmacol. 1989 Nov;28(5):581-5.

18.

Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine.

Daneshmend TK, Prichard PJ, Bhaskar NK, Millns PJ, Hawkey CJ.

Gastroenterology. 1989 Oct;97(4):944-9.

PMID:
2570732
19.

Failure of ethamsylate to reduce aspirin-induced gastric mucosal bleeding in humans.

Daneshmend TK, Stein AG, Bhaskar NK, Hawkey CJ.

Br J Clin Pharmacol. 1989 Jul;28(1):109-12.

20.

Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin.

Prichard PJ, Kitchingman GK, Walt RP, Daneshmend TK, Hawkey CJ.

BMJ. 1989 Feb 25;298(6672):493-6.

21.

Devastating diarrhoea caused by azathioprine: management difficulty in inflammatory bowel disease.

Cox J, Daneshmend TK, Hawkey CJ, Logan RF, Walt RP.

Gut. 1988 May;29(5):686-8.

22.

Resistant duodenal ulcer: when, why and what to do?

Walt RP, Daneshmend TK.

Postgrad Med J. 1988 May;64(751):369-72. No abstract available.

23.

Effect of stanozolol on itching in primary biliary cirrhosis.

Walt RP, Daneshmend TK, Fellows IW, Toghill PJ.

Br Med J (Clin Res Ed). 1988 Feb 27;296(6622):607. No abstract available.

24.

Clinical pharmacokinetics of ketoconazole.

Daneshmend TK, Warnock DW.

Clin Pharmacokinet. 1988 Jan;14(1):13-34. Review.

PMID:
3280211
25.

14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach.

Bell GD, Weil J, Harrison G, Morden A, Jones PH, Gant PW, Trowell JE, Yoong AK, Daneshmend TK, Logan RF.

Lancet. 1987 Jun 13;1(8546):1367-8. No abstract available.

PMID:
2884468
26.

Phenytoin (Epanutin) Associated Hodgkin's Disease.

Daneshmend TK, Davies JD.

Bristol Med Chir J. 1987 May;102(2):35-50.

27.

Oxamniquine pharmacokinetics in hepatosplenic schistosomiasis in the Sudan.

Daneshmend TK, Homeida MA.

J Antimicrob Chemother. 1987 Jan;19(1):87-93.

PMID:
3104279
28.

Systemic absorption of miconazole from the vagina.

Daneshmend TK.

J Antimicrob Chemother. 1986 Oct;18(4):507-11.

PMID:
3771433
29.

Ketoconazole pharmacokinetics during chronic dosing in adults with haematological malignancy.

Stockley RJ, Daneshmend TK, Bredow MT, Warnock DW, Richardson MD, Slade RR.

Eur J Clin Microbiol. 1986 Oct;5(5):513-7.

PMID:
3465533
30.

Influence of formulation on ketoconazole pharmacokinetics in man: comparison of standard tablet versus capsule containing citric acid.

Daneshmend TK, Mason AR, Lowe CH, Warnock DW, Johnson EM.

J Antimicrob Chemother. 1986 Aug;18(2):289-91. No abstract available.

PMID:
3759737
31.

Metronidazole metabolism following oral benzoylmetronidazole suspension in children with giardiasis.

Homeida MA, Daneshmend TK, Ali HM, Kaye CM.

J Antimicrob Chemother. 1986 Aug;18(2):213-9.

PMID:
3759732
32.

Assessment of oxidative metabolism in adults with hepatocellular carcinoma in the Sudan.

Homeida MM, Daneshmend TK, Ali EM, Yousif-Elkadaru AG, Arbab BM.

Gut. 1986 Apr;27(4):382-5.

33.

Painful urticaria heralding the appearance of Philadelphia chromosome positive acute myeloid leukaemia.

Stockley RJ, Daneshmend TK.

Clin Lab Haematol. 1986;8(2):161-2. No abstract available.

PMID:
3460730
34.

Need for antibiotic prophylaxis during hair electrolysis?

Daneshmend TK.

Br Med J (Clin Res Ed). 1984 Dec 15;289(6459):1693. No abstract available.

35.

Aflatoxin, hepatocellular carcinoma, and schistosomiasis.

Daneshmend TK.

Lancet. 1984 Dec 15;2(8416):1393-4. No abstract available.

PMID:
6150387
36.

Do beta blockers differ in their effects on hepatic microsomal enzymes and liver blood flow?

Parker G, Ene MD, Daneshmend TK, Roberts CJ.

J Clin Pharmacol. 1984 Nov-Dec;24(11-12):493-9.

PMID:
6150945
37.

The effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics.

Daneshmend TK, Roberts CJ.

Br J Clin Pharmacol. 1984 Sep;18(3):393-400.

38.

Haemoptysis during sexual intercourse.

Daneshmend TK.

Br Med J (Clin Res Ed). 1984 May 19;288(6429):1537. No abstract available.

39.

Impaired elimination of metronidazole in decompensated chronic liver disease.

Daneshmend TK, Roberts CJ.

Br Med J (Clin Res Ed). 1984 Feb 4;288(6414):405. No abstract available.

40.
41.

Increased hepatitis B infection in hepatosplenic schistosomiasis in the Sudan.

Daneshmend TK, Homeida M, Satir AA, Vandervelde EM.

East Afr Med J. 1984 Feb;61(2):133-5. No abstract available.

PMID:
6468320
42.

Systemic absorption of ketoconazole from vaginal pessaries.

Ene MD, Williamson PJ, Daneshmend TK, Blatchford NR.

Br J Clin Pharmacol. 1984 Feb;17(2):173-5.

43.

Acute brain stem stroke during neck manipulation.

Daneshmend TK, Hewer RL, Bradshaw JR.

Br Med J (Clin Res Ed). 1984 Jan 21;288(6412):189. No abstract available.

44.

Influence of food on the pharmacokinetics of ketoconazole.

Daneshmend TK, Warnock DW, Ene MD, Johnson EM, Potten MR, Richardson MD, Williamson PJ.

Antimicrob Agents Chemother. 1984 Jan;25(1):1-3.

45.

The neurotoxicity of dapsone.

Daneshmend TK.

Adverse Drug React Acute Poisoning Rev. 1984 Spring;3(1):43-58. Review. No abstract available.

PMID:
6091422
46.

Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man.

Daneshmend TK, Warnock DW, Ene MD, Johnson EM, Parker G, Richardson MD, Roberts CJ.

J Antimicrob Chemother. 1983 Aug;12(2):185-8.

PMID:
6311786
47.

Isotretinoin (13cis-retinoic acid) and serum lipids.

Daneshmend TK, Paisey R.

Br J Dermatol. 1983 Jul;109(1):124-5. No abstract available.

PMID:
6222754
48.

Clinical pharmacokinetics of systemic antifungal drugs.

Daneshmend TK, Warnock DW.

Clin Pharmacokinet. 1983 Jan-Feb;8(1):17-42. Review. No abstract available.

PMID:
6301738
49.

Ketoconazole-cyclosporin interaction.

Daneshmend TK.

Lancet. 1982 Dec 11;2(8311):1342-3. No abstract available.

PMID:
6128627
50.

Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis.

Daneshmend TK, Homeida M, Kaye CM, Elamin AA, Roberts CJ.

Gut. 1982 Oct;23(10):807-13.

Supplemental Content

Loading ...
Support Center